Ephraim Resources Limited Stock

Stocks

EPA

AU000000EPA3

Biotechnology & Medical Research

End-of-day quote 23:47:55 2017-02-27 EST 5-day change 1st Jan Change
0.002000 AUD +100.00% Intraday chart for Ephraim Resources Limited +100.00% -

Valuation: Ephraim Resources Limited

Market Cap 3.08M 2.8M 2.58M 2.33M 4.4M 288M 4.57M 31.12M 12.31M 155M 11.56M 11.31M 491M P/E 2017
-6.41x
P/E 2018 -3.16x
Enterprise Value 3.63M 3.29M 3.04M 2.74M 5.18M 339M 5.38M 36.66M 14.5M 183M 13.61M 13.33M 578M EV / Sales 2017
223x
EV / Sales 2018 29,261x
Free-Float
68.23%
Yield 2017 *
-
Yield 2018 -
Manager TitleAgeSince
President - -
Chief Operating Officer - -
Corporate Secretary 60 2020-01-27
Director TitleAgeSince
Director/Board Member 60 2020-01-16
Director/Board Member - -
Director/Board Member - -
Change 5-day change 1-year change 3-year change Capi.($)
+100.00%+100.00% - - 2.09M
+1.15%-2.81%+55.79%+71.12% 65.56B
-2.64%-1.13%+7.82%+88.90% 60.41B
-1.07%+0.30%+22.91%+86.76% 55.76B
+0.48%-2.53%+9.73%+121.14% 46.98B
-2.69%-6.38%+19.19%+25.79% 43.63B
-0.70%+4.93%+17.77%+45.03% 36.7B
-2.50%-15.73%+135.31%+662.73% 36.09B
-0.77%-2.21%+77.27%+57.96% 32.9B
-0.83%+1.98%-38.27%+390.98% 26.96B
Average +9.04%+7.94%+34.17%+172.27% 40B
Weighted average by Cap. -0.99%-2.21%+33.95%+147.43%

Financials

2017 2018
Net sales 16.01K 14.53K 13.43K 12.11K 22.87K 1.5M 23.74K 162K 63.99K 807K 60.07K 58.8K 2.55M 124 112.57 103.99 93.81 177.1 11.59K 183.88 1.25K 495.59 6.25K 465.24 455.44 19.75K
Net income -481K -437K -403K -364K -687K -44.94M -713K -4.86M -1.92M -24.25M -1.8M -1.77M -76.61M -976K -886K -818K -738K -1.39M -91.15M -1.45M -9.86M -3.9M -49.18M -3.66M -3.58M -155M
Net Debt 497K 451K 417K 376K 709K 46.41M 737K 5.02M 1.99M 25.04M 1.86M 1.82M 79.12M 548K 498K 460K 415K 783K 51.23M 813K 5.54M 2.19M 27.64M 2.06M 2.01M 87.34M
Logo Ephraim Resources Limited
Lanka Graphite Ltd is an Australia-based company. The Company is engaged in the business of agricultural biogenetics research and experimentation, licensing and consultancy. The Company focuses on nipah palm breeding, tissue culture, cultivation and plantation, and the conversion of sap from the nipah palm to sugar and ethanol. The Company operates through two segments: Australia and Indonesia.
Employees
-